DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

DOD-AMRAA HT942526BCRPTBCCDA
Posted: May 04, 2026 12:00:00 AM EDT
Closes: 07/08/2026

Funding Information

Estimated Total Funding
$140,000
Expected Number of Awards
1

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:·        This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms.·        Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA.

Synopsis

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Distinctive Features:

·        This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms.

·        Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA.

Eligibility

Eligible Applicants:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Funding Activity Categories

Science and Technology and other Research and Development

CFDA Numbers

  • 12.420 - Military Medical Research and Development

Contact Information

Agency: Jamie Shortall Grant Officer
Contact: Jamie Shortall Grant Officer
Phone: 301-619-2393
eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org

Additional Information

Document Type: synopsis
Opportunity Category: Discretionary
Version: 1
Last Updated: May 04, 2026 12:54:35 PM EDT

Related Opportunities